Experience
Genzyme Corporation v. Sarepta Therapeutics, Inc. et al.
Genzyme Corporation
Sarepta Therapeutics, Inc. et al.
Representing Sarepta in defensive patent litigation involving Elevidys®, a one-time gene therapy for the treatment of a neuromuscular disease known as Duchenne muscular dystrophy (DMD) and in parallel offensive inter partes reviews (IPRs).
Genzyme Corporation v. Sarepta Therapeutics, Inc. et al., 1:24-cv-00882, D. Del., Judge Andrews
